Sarmed H. Kathem

406 total citations
27 papers, 288 citations indexed

About

Sarmed H. Kathem is a scholar working on Molecular Biology, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Sarmed H. Kathem has authored 27 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Genetics and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Sarmed H. Kathem's work include Genetic and Kidney Cyst Diseases (7 papers), Nigella sativa pharmacological applications (4 papers) and Cancer therapeutics and mechanisms (4 papers). Sarmed H. Kathem is often cited by papers focused on Genetic and Kidney Cyst Diseases (7 papers), Nigella sativa pharmacological applications (4 papers) and Cancer therapeutics and mechanisms (4 papers). Sarmed H. Kathem collaborates with scholars based in Iraq and United States. Sarmed H. Kathem's co-authors include Surya M. Nauli, Ashraf M. Mohieldin, Wissam A. AbouAlaiwi, Brian S. Muntean, Waleed K. Abdulsahib, Jing Zhou, Rajasekharreddy Pala, Jian‐Guo Zheng, Andromeda M. Nauli and Munaf H. Zalzala and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nano Letters and ACS Nano.

In The Last Decade

Sarmed H. Kathem

26 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarmed H. Kathem Iraq 10 139 109 34 25 25 27 288
Lishan Yang China 9 39 0.3× 98 0.9× 10 0.3× 8 0.3× 7 0.3× 23 255
Zhimin Cao United States 11 47 0.3× 92 0.8× 8 0.2× 14 0.6× 15 0.6× 20 306
Xiaohe Zheng China 11 48 0.3× 264 2.4× 19 0.6× 10 0.4× 3 0.1× 23 467
Mohit Mehndiratta India 12 28 0.2× 146 1.3× 22 0.6× 8 0.3× 6 0.2× 52 385
Ye Tao China 9 30 0.2× 109 1.0× 17 0.5× 8 0.3× 17 0.7× 29 281
Ighli di Bari Italy 9 81 0.6× 187 1.7× 23 0.7× 3 0.1× 19 0.8× 15 339
Christopher Rice United States 8 34 0.2× 164 1.5× 13 0.4× 6 0.2× 5 0.2× 12 323
Kunkai Su China 12 87 0.6× 135 1.2× 26 0.8× 21 0.8× 3 0.1× 29 366
Xianlun Yin China 5 33 0.2× 218 2.0× 18 0.5× 7 0.3× 9 0.4× 8 318

Countries citing papers authored by Sarmed H. Kathem

Since Specialization
Citations

This map shows the geographic impact of Sarmed H. Kathem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarmed H. Kathem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarmed H. Kathem more than expected).

Fields of papers citing papers by Sarmed H. Kathem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarmed H. Kathem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarmed H. Kathem. The network helps show where Sarmed H. Kathem may publish in the future.

Co-authorship network of co-authors of Sarmed H. Kathem

This figure shows the co-authorship network connecting the top 25 collaborators of Sarmed H. Kathem. A scholar is included among the top collaborators of Sarmed H. Kathem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarmed H. Kathem. Sarmed H. Kathem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kathem, Sarmed H., et al.. (2025). L-carvone alleviates lipopolysaccharide-Induced acute kidney injury via modulating MyD88-dependent and independent signaling pathways in Mice. Molecular Biology Reports. 53(1). 39–39. 3 indexed citations
3.
Jamal, Mostofa & Sarmed H. Kathem. (2024). Citronellol protects renal function by exerting anti-inflammatory and antiapoptotic effects against acute kidney injury induced by folic acid in mice. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(5). 5927–5937.
4.
Kathem, Sarmed H., et al.. (2024). Limonene Exerts Anti-Inflammatory Effect on LPS-Induced Jejunal Injury in Mice by Inhibiting NF-κB/AP-1 Pathway. Biomolecules. 14(3). 334–334. 22 indexed citations
5.
Kathem, Sarmed H., et al.. (2022). Gentiopicroside ameliorates lipopolysaccharide-induced acute kidney injury by inhibiting TLR4/NF-κB signaling in mice model. Journal of Pharmaceutical Negative Results. 13(4). 5 indexed citations
6.
Kathem, Sarmed H., Waleed K. Abdulsahib, & Munaf H. Zalzala. (2022). Berbamine and thymoquinone exert protective effects against immune-mediated liver injury via NF-κB dependent pathway. Frontiers in Veterinary Science. 9. 960981–960981. 13 indexed citations
9.
Al‐Jumaili, Ali Azeez, et al.. (2021). The Students’ Experience of Hybrid- Education Model at the University of Baghdad College of Pharmacy: Lessons and Future Directions. SHILAP Revista de lepidopterología. 1 indexed citations
10.
Kathem, Sarmed H., et al.. (2021). Thymoquinone Attenuates Immune Mediated Liver Injury Induced by Concanavalin A in Mice. SHILAP Revista de lepidopterología. 30(2). 50–57. 7 indexed citations
11.
Kathem, Sarmed H., et al.. (2021). Measuring depression and anxiety prevalence among Iraqi healthcare college students using hospital anxiety and depression scale. Pharmacy Practice. 19(2). 2303–2303. 15 indexed citations
12.
Al‐Jumaili, Ali Azeez, et al.. (2021). Students Experience of Hybrid- Education Model at The University of Baghdad College of Pharmacy. SHILAP Revista de lepidopterología. 30(2). 269–277. 4 indexed citations
13.
Kathem, Sarmed H., et al.. (2021). Carvone Attenuates Irinotecan-Induced Intestinal Mucositis and Diarrhea in Mice. SHILAP Revista de lepidopterología. 30(2). 58–63. 9 indexed citations
14.
Kathem, Sarmed H., et al.. (2020). Nigella Sativa Seed Oil Effectively Attenuates Cyclophosphamide‐Induced Myelosuppression in Mice. The FASEB Journal. 34(S1). 1–1. 2 indexed citations
15.
Kathem, Sarmed H., et al.. (2020). Evaluation of the Possible Immuno-Protective Effect of Nigella Sativa Seed Oil on Cyclophosphamide- Induced Myelosuppression in Mice. SHILAP Revista de lepidopterología. 29(1). 253–259. 1 indexed citations
16.
Kathem, Sarmed H., et al.. (2019). The Protective Effect of Mentha spicata Ethanolic Extract on Irinotecan-Induced Mucositis in Mice. Iraqi Journal of Pharmaceutical Sciences ( P-ISSN 1683 - 3597 E-ISSN 2521 - 3512). 28(1). 37–43. 8 indexed citations
17.
Kathem, Sarmed H., et al.. (2019). The Protective Effect of Ethanolic Extract of Mentha spicata Against Irinotecan-Induced Mucositis in mice. SHILAP Revista de lepidopterología. 28(1). 37–43. 4 indexed citations
18.
Kathem, Sarmed H., Xingjian Jin, Brian S. Muntean, et al.. (2015). Dopaminergic signaling within the primary cilia in the renovascular system. Frontiers in Physiology. 6. 103–103. 13 indexed citations
19.
Muntean, Brian S., et al.. (2014). Roles of dopamine receptor on chemosensory and mechanosensory primary cilia in renal epithelial cells. Frontiers in Physiology. 5. 72–72. 41 indexed citations
20.
Kathem, Sarmed H., Ashraf M. Mohieldin, & Surya M. Nauli. (2013). The Roles of Primary cilia in Polycystic Kidney Disease. SHILAP Revista de lepidopterología. 1(1). 27–46. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026